Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents [Phase 4]
Phase 4 clinical trial evaluating two topical hypotensive medications with two iStents in subjects with primary open-angle glaucoma.
-
FDA approval · 2022-09-07FDA Approved: TIMOLOL MALEATE — Original Application (Micro Labs Limited)
FDA approved timolol maleate from Micro Labs Limited under an original application (ANDA) for lowering intraocular pressure in open-angle gl…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry [NA]
Clinical trial update comparing visuALL Field Analyzer to standard Humphrey automated perimetry in glaucoma subjects has completed with resu…
-
FDA approval · 2022-06-24FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION — Original Application (FOSUN PHARMA USA INC)
FDA approved TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION from Fosun Pharma USA Inc as an original ANDA product for lowering intraocular …
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma [NA]
A multicenter prospective trial of the OMNI Surgical System in pseudophakic eyes with open-angle glaucoma was terminated; results were poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Ahmed Glaucoma Valve Surgery With Mitomycin-C [Phase 2]
Phase 2 trial update for Ahmed Glaucoma Valve surgery with Mitomycin-C in glaucoma patients; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Study of LL-BMT1 in Patients With Elevated Intraocular Pressure [Phase 2]
Phase 2 clinical trial of LL-BMT1 in patients with elevated intraocular pressure has completed with results posted.
-
FDA approval · 2022-04-20FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Apotex Corp.)
FDA approved Apotex's brimonidine tartrate/timolol maleate ophthalmic solution as an Original Application generic to lower intraocular press…
-
CLINICAL_TRIALS withdrawal · 2022-04-07Clinical Trial Update: Pilocarpine After Combined Cataract/Trabectome Surgery [Phase 3]
Phase 3 trial of pilocarpine after combined cataract/trabectome surgery was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma [Phase 4]
Clinical trial update reporting on the efficacy and safety of the XEN Gel Stent and post-operative management in open-angle glaucoma (Phase …
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl [Phase 4]
A Phase 4 study evaluating switching from prostaglandin monotherapy to omidenepag isopropyl for prostaglandin-associated peri-orbitopathy in…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Evaluation of Safety and Efficacy of PDP-716 [Phase 3]
Phase 3 clinical trial evaluating PDP-716 for open angle glaucoma and ocular hypertension has completed with results posted in 2022.
-
FDA approval · 2022-01-28FDA Approved: TAFLUPROST — Original Application (Sandoz Inc)
FDA approves Sandoz's Tafluprost as an original application (ANDA) for generic tafluprost indicated to reduce intraocular pressure in open-a…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) ophthalmic solution to GANFORT in open-angle glaucoma and ocular hyper…
-
FDA approval · 2021-12-13FDA Approved: TIMOPTIC IN OCUDOSE — Original Application (Nordic Pharma, Inc.)
FDA approves Nordic Pharma's TIMOPTIC IN OCUDOSE (timolol maleate) under an original ANDA application.
-
CLINICAL_TRIALS withdrawal · 2021-11-19Clinical Trial Update: A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing SDP-133 (Sun Pharma) daily with Lumigan in open-angle glaucoma or ocular hypertension was withdrawn.
-
FDA approval · 2021-10-28FDA Approved: PHOSPHOLINE IODIDE — Supplemental Application (Fera Pharmaceuticals, LLC)
FDA approved a supplemental application for phospholine iodide (echothiophate iodide for ophthalmic solution) from Fera Pharmaceuticals, LLC…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT [Phase 3]
Phase 3 trial evaluating safety and efficacy of OTX-TP in open angle glaucoma and ocular hypertension has completed with results posted.
-
FDA approval · 2021-09-23FDA Approved: BRIMONIDINE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's original application for Brimonidine, a generic ophthalmic solution, for lowering elevated…
-
FDA approval · 2021-09-03FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for latanoprost by Bausch & Lomb Incorporated to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Nailfold Capillary Blood Flow With Latanoprost Bunod [Phase 4]
Phase 4 trial update evaluating nailfold capillary blood flow with latanoprost bunod in open-angle glaucoma has completed; results posted in…
-
FDA approval · 2021-08-18FDA Approved: BRINZOLAMIDE — Original Application (Oceanside Pharmaceuticals.)
FDA approved the original application for brinzolamide from Oceanside Pharmaceuticals, establishing a generic version of the ophthalmic drug…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: H-1337 Ophthalmic Solution Phase 1/2 [Phase 1, Phase 2]
Phase 1/2 study of H-1337 ophthalmic solution for glaucoma (open-angle) completed; results posted.
-
FDA label_change · 2021-06-22FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for brinzolamide by Sandoz Inc. to update the product labeling. The update may reflect changes to in…
-
CLINICAL_TRIALS withdrawal · 2021-06-21Clinical Trial Update: African Glaucoma Laser Trial [Phase 4]
A Phase 4 clinical trial on open-angle glaucoma conducted in Africa has been withdrawn.